51Talk COE Q3 2025 Earnings Wider Loss Weighs on Shares as Revenue Details Remain Unclear PharmaCyte Biotech PMCB Q1 2026 Earnings Narrowing Loss Amid Strategic Pipeline Progress PFXNZ Q1 2026 Earnings EPS Surges Past Estimates by 254 Amid Strong Portfolio Performance MX Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Rally SU Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Strength AIN Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength